For Long Life | GenomeWeb

For Long Life

With about $70 million in financing, Craig Venter has launched a new company called Human Longevity that plans to combine omic and clinical data to develop diagnostics and therapies for aging-related diseases and allow people to live longer, GenomeWeb Daily News reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Diving in Deep

Breaching the Barrier

From Scratch

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.